The latest development in the Pradaxa multidistrict litigation (MDL) in the U.S. District Court for the Southern District of Illinois involves a recently filed court document from mid-September. Both parties convened on September 18, 2013 to discuss issues that have arisen during the discovery process.
The court met to review two motions filed by the plaintiffs, a Motion to Compel and a Motion for sanctions. A Motion to Compel is a request that the court compel action in the other party involved in the lawsuit. A Motion for Sanctions points to the other party’s inability to act in accordance with court orders.
As to the plaintiffs’ Motion for Sanctions, the court ultimately concluded during the meeting that the defendant is not acting in accordance with the court’s orders.
As an advocate of those who claim to have been injured by Pradaxa, Carey Danis & Lowe class action attorneys consider the inability to fulfill the court’s orders as having a significant slowing effect on the multidistrict litigation process. This is most unfortunate, as MDLs are designed to efficiently handle thousands of similar cases.
Carey Danis & Lowe Pradaxa attorneys hope that the defendants in the Pradaxa MDL will quickly organize to better comply with orders.
Our Pradaxa attorneys are currently accepting Pradaxa cases, and are offering free legal evaluations of these cases. The Carey Danis & Lowe team is here to support you and your loved one with expert legal advice.
Also, contact Carey Danis & Lowe’s on-staff medical experts for information about health issues related to the use of Pradaxa. Plaintiffs have filed Pradaxa lawsuits after experiencing serious bleeding events that in some cases have been fatal.
Share your Pradaxa story with Carey Danis & Lowe by calling 800.721.2519, or by submitting a confidential personal injury claim form.References: Pharmaceutical litigation, Pradaxa